← Scoopfeeds — Intelligent news, curated.
BofA reiterates Buy on AstraZeneca stock, cites adjuvant trial outlook
business

BofA reiterates Buy on AstraZeneca stock, cites adjuvant trial outlook

Investing.com · Jun 9, 2026, 7:42 AM · Also reported by 1 other source

BofA reiterates Buy on AstraZeneca stock, cites adjuvant trial outlook

Read full story on Investing.com → More top stories

Also covered by

MarketWatch BofA sees ‘red flags’ in the U.S. stock market. Here’s what to buy now.

More in business

Investing.com
European bond yields ease ahead of ECB meeting, Middle East risks linger
Investing.com
Earnings call transcript: LBG Media’s Q1 2026 results show revenue growth but stock tumbles
Investing.com
Applied Digital stock holds at outperform on hyperscaler deal
Investing.com
Citizens upgrades Lyell Immunopharma stock rating on safety data
Investing.com
Barclays reiterates Apple stock Underweight rating after developer event
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop